Medical Genetics, Clinical Molecular Genetics · Indianapolis, IN
NPI
1154431567
Since 2006
Specialty
Medical Genetics, Clinical Molecular Genetics
Code 207SG0203X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1002 Wishard Blvd
Indianapolis, IN, 46202
Phone (317) 944-3966
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,123
45 services
Medicare patients, 2024
37
Average age 47
Drug cost, 2024
$3.9M
209 prescriptions
Company payments, 2025
$23.41
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bryan E Hainline was code 99215 (office e&m - established), 42 times for 35 patients. In total Bryan E Hainline billed 45 services in 2 codes, and Medicare paid $5,123.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 42 | 35 | $113.30 | $4,758 |
By year: 2022 $4,537 for 41 services; 2023 $5,059 for 46 services; 2024 $5,123 for 45 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bryan E Hainline prescribed most often to Medicare patients was Levocarnitine (Levocarnitine (With Sugar)), with 48 prescriptions and refills. In total Bryan E Hainline wrote 209 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocarnitine Levocarnitine (With Sugar) | 48 | 72 | Under 11 | $9,414 |
| Sapropterin Dihydrochloride Generic | 26 | 26 | Under 11 | $254K |
| Ravicti Glycerol Phenylbutyrate | 24 | 24 | Under 11 | $2.3M |
| Cystadane Betaine | 19 | 19 | Under 11 | $16K |
| Levocarnitine Generic | 16 | 32 | Under 11 | $1,734 |
| Vimizim Elosulfase Alfa | 14 | 14 | Under 11 | $1.1M |
Brand drugs: 75 claims; generic drugs: 134 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bryan E Hainline $23.41 ($23.41 in general payments such as food, travel and fees) from 1 company. The largest payer was Sandoz Inc. with $23.41.
| Company | Payments | Amount |
|---|---|---|
| Sandoz Inc. SDZ.SW | 1 | $23.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.